Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer. - Wikidata - wikimedia - TriplyDB

Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer.

Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer.

http://www.wikidata.org/entity/Q37652110

about

Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.Interactive Volumetry Of Liver Ablation Zones.Hepatic radioembolization as a bridge to liver surgery.

P2860

Q35921769-CA30F105-F9EA-4D57-A90D-67E9510DE707 Q36182474-83D50A8E-E6DB-411E-BA23-08CFA2D4AD5F Q38240151-EDA562BB-C2D6-44ED-B2D3-391AAEDABE68

P2860

Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer.

http://www.wikidata.org/entity/Q37652110

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic efficacy compariso ...... a and metastatic liver cancer.

@en

Therapeutic efficacy compariso ...... a and metastatic liver cancer.

@nl

type

label

Therapeutic efficacy compariso ...... a and metastatic liver cancer.

@en

Therapeutic efficacy compariso ...... a and metastatic liver cancer.

@nl

prefLabel

Therapeutic efficacy compariso ...... a and metastatic liver cancer.

@en

Therapeutic efficacy compariso ...... a and metastatic liver cancer.

@nl

P1433

Q37652110-6F628DF3-EA4D-4A57-A23E-AA737D3B9F10

P1476

Q37652110-8C352ED3-78A9-43FB-BB84-761F155FAEDC

P2093

Q37652110-938A2AD5-40E0-4BF7-BB38-64CFDC027AEE

Q37652110-D7C2639F-6EEA-4FB2-9FD5-51B4E381DB72

P2860

Q37652110-2735A4C9-9C3A-4AD8-B0EE-C630D4BB6D68

Q37652110-2E98A2B7-6F84-485F-A0E7-736D0C59D18D

Q37652110-2F271952-F590-4613-BE86-0D579F60DAA3

Q37652110-30A4E4CE-CA75-48F4-A551-C268288CDE7F

Q37652110-4A94EF5C-3B96-4ACD-BACE-656FE5684829

Q37652110-5CD44E6A-40A5-4CDF-A866-BD4C17DDDF6E

Q37652110-6D6D0521-E12A-4884-AC5C-F87E0EAC83A1

Q37652110-6FBAE424-CB2E-4215-A745-D634AEB4FE4C

Q37652110-8466FBB9-B9BA-4E3A-B4A8-2B423A71C64D

Q37652110-8A3705BB-5CB8-4005-A6BA-316723DE7D4B

P304

Q37652110-AB90F572-4C2A-46B9-AFA8-F6F1B145D0F0

P31

Q37652110-0C8B48B3-D3F4-4125-8893-E727F9AA2012

P356

Q37652110-ECC355A6-35BC-4B59-B13F-9ACE62F47DBD

P433

Q37652110-62A32C90-A9A9-49CB-AC1F-93EA99A5EA6A

P478

Q37652110-B62AD41A-ADA7-457A-88E3-BEA0DA358BD5

P577

Q37652110-62D2777F-6B47-47D7-ABD1-11968A15EADC

P5875

Q37652110-89322C6E-0ED8-498D-9563-6C253A90CBFB

P698

Q37652110-16492EA6-E41C-4235-A4CF-BC10CB96544A

P932

Q37652110-C040E875-A686-4F61-9BF5-7EAC9AE290DC

P356

P1433

Experimental and Therapeutic Medicine

P1476

Therapeutic efficacy compariso ...... a and metastatic liver cancer.

@en

P2093

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Lin-Xue Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

Resection vs thermal ablation of small hepatocellular carcinoma: What's the first choice?

A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010.

Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.

Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.

P304

897-900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2014.1505

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261106354

http://www.w3.org/2001/XMLSchema#string

P698

24669247

http://www.w3.org/2001/XMLSchema#string

P932

3961118

http://www.w3.org/2001/XMLSchema#string